NewGenIvf Group Statistics
Total Valuation
NewGenIvf Group has a market cap or net worth of $1.23 million. The enterprise value is $5.15 million.
Important Dates
The next estimated earnings date is Wednesday, April 22, 2026.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NewGenIvf Group has 568,542 shares outstanding.
| Current Share Class | 568,473 |
| Shares Outstanding | 568,542 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +287.33% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 0.50% |
| Float | 568,473 |
Valuation Ratios
The trailing PE ratio is 0.71 and the forward PE ratio is 0.46.
| PE Ratio | 0.71 |
| Forward PE | 0.46 |
| PS Ratio | 0.26 |
| Forward PS | n/a |
| PB Ratio | 0.02 |
| P/TBV Ratio | 0.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 0.52 |
| EV / Sales | 1.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.12 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.40 |
Financial Efficiency
Return on equity (ROE) is 79.40% and return on invested capital (ROIC) is -33.70%.
| Return on Equity (ROE) | 79.40% |
| Return on Assets (ROA) | -36.94% |
| Return on Invested Capital (ROIC) | -33.70% |
| Return on Capital Employed (ROCE) | -35.34% |
| Weighted Average Cost of Capital (WACC) | 8.94% |
| Revenue Per Employee | $54,327 |
| Profits Per Employee | $113,556 |
| Employee Count | 87 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 15.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.74% in the last 52 weeks. The beta is 0.09, so NewGenIvf Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -99.74% |
| 50-Day Moving Average | 2.47 |
| 200-Day Moving Average | 56.20 |
| Relative Strength Index (RSI) | 45.89 |
| Average Volume (20 Days) | 25,804 |
Short Selling Information
The latest short interest is 46,988, so 8.26% of the outstanding shares have been sold short.
| Short Interest | 46,988 |
| Short Previous Month | 48,940 |
| Short % of Shares Out | 8.26% |
| Short % of Float | 8.27% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, NewGenIvf Group had revenue of $4.73 million and earned $9.88 million in profits. Earnings per share was $3.04.
| Revenue | 4.73M |
| Gross Profit | 955,846 |
| Operating Income | -10.73M |
| Pretax Income | 9.73M |
| Net Income | 9.88M |
| EBITDA | -10.54M |
| EBIT | -10.73M |
| Earnings Per Share (EPS) | $3.04 |
Full Income StatementBalance Sheet
The company has $958,556 in cash and $4.87 million in debt, with a net cash position of -$3.91 million or -$6.88 per share.
| Cash & Cash Equivalents | 958,556 |
| Total Debt | 4.87M |
| Net Cash | -3.91M |
| Net Cash Per Share | -$6.88 |
| Equity (Book Value) | 25.99M |
| Book Value Per Share | 110.50 |
| Working Capital | 5.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.93 million and capital expenditures -$135,025, giving a free cash flow of -$11.06 million.
| Operating Cash Flow | -10.93M |
| Capital Expenditures | -135,025 |
| Depreciation & Amortization | 188,109 |
| Net Borrowing | 6.19M |
| Free Cash Flow | -11.06M |
| FCF Per Share | -$19.46 |
Full Cash Flow StatementMargins
Gross margin is 20.22%, with operating and profit margins of -226.95% and 209.02%.
| Gross Margin | 20.22% |
| Operating Margin | -226.95% |
| Pretax Margin | 205.84% |
| Profit Margin | 209.02% |
| EBITDA Margin | -222.97% |
| EBIT Margin | -226.95% |
| FCF Margin | n/a |
Dividends & Yields
NewGenIvf Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 800.77% |
| FCF Yield | -896.55% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on March 16, 2026. It was a reverse split with a ratio of 1:4.
| Last Split Date | Mar 16, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
NewGenIvf Group has an Altman Z-Score of -0.13 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.13 |
| Piotroski F-Score | 2 |
